Brenton Saunders

Mr. Saunders is currently the Executive Chairman of the Beauty Health Company.

He was formerly Chairman, President and Chief Executive Officer of Allergan. He served in the role of President and Chief Executive Officer starting in July 2014 and in the role of Chairman starting in October 2016. Mr. Saunders also served as Director of Forest Laboratories, Inc. prior to its acquisition by Allergan.

Prior to that, Mr. Saunders was the Chief Executive Officer of Bausch + Lomb Incorporated, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Mr. Saunders also held a number of leadership positions at Schering-Plough, including the position of President of Global Consumer Health Care, and was named Head of Integration for the company’s merger with Merck & Co. and for its acquisition of Organon BioSciences. Before joining Schering-Plough, Mr. Saunders was a partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Mr. Saunders began his career as Chief Compliance Officer for the Thomas Jefferson University Health System.

Mr. Saunders serves on the Board of Directors of Cisco Systems, Inc. and BridgeBio Inc., and he is a member of the Business Council.